Helocyte's Spinoff / Spinout Round

Helocyte raised a round of funding on April 02, 2015. Investors include Fortress Biotech.

Helocyte, formerly DiaVax Biosciences, is a clinical-stage company developing novel immunotherapies for the prevention and treatment of cancer and infectious disease (and in particular, cytomegaloviru…

Articles about Helocyte's Spinoff / Spinout Round: